Company intelligence / Profile preview
Metuas Medical
- Ownership
- Private
- Development stage
- Other
Overview
Metuas Medical is a Turkish medical device and biotechnology company founded in 2011, specializing in non-invasive treatments for spinal conditions. The company's flagship product, the Artcure Diffusional Patch, is a transdermal patch containing a proprietary blend of six herbal oils designed to mechanically reduce the mass of herniated discs. By leveraging osmotic pressure and diffusion, the patch alleviates nerve compression in patients with lumbar and cervical disc herniation. Metuas also develops products for algology, neurosurgery, orthopedics, and skincare, maintaining a presence in both local and international markets.
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- DeviceHerbal medicinePlant extract
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Metuas Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Metuas Medical.